Stock NOVO B NOVO NORDISK A/S
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Market Closed - Nasdaq Copenhagen
Other stock markets
 15:59:31 31/05/2024 BST 		5-day change 1st Jan Change
927.3 DKK +1.13% Intraday chart for Novo Nordisk A/S -0.16% +32.83%
05-31 Zealand Pharma Secures EU Panel Backing for Severe Hypoglycemia Treatment MT
05-30 Danish Government Implements Stricter Subsidy Rules for Diabetes Drugs MT

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Zealand Pharma Secures EU Panel Backing for Severe Hypoglycemia Treatment
MT
Danish Government Implements Stricter Subsidy Rules for Diabetes Drugs
MT
Wegovy maker Novo Nordisk sues nine spas, clinics and pharmacies over copycat drugs
RE
EARNINGS AND TRADING: First Tin "consolidates" holdings in Taronga
AN
Catalent Shareholders Approve Deal With Novo Holdings
MT
Catalent stockholders approve deal with Novo Holdings
RE
Sector Update: Health Care Stocks Fall Late Afternoon
MT
Annual sales of weight-loss drugs seen hitting $150 billion
RE
Sector Update: Health Care Stocks Retreat Tuesday Afternoon
MT
Novo Nordisk Tells US Senate Health Committee Chair Sanders It Only Keeps 60% of Ozempic, Wegovy List Price
MT
Novo Nordisk's Boost to Danish Employment Levels More than Expected, Economic Councils Says
MT
Novo Nordisk Said to Defend Drug Prices Amid Heat from US Lawmakers
MT
Weight-loss drug forecasts jump to $150 billion as supply grows
RE
Novo Nordisk: share buybacks continue
CF
Wegovy users have less kidney-related health problems, analysis of Novo study finds
RE
Health Care Down on Rotation Out of Sector - Health Care Roundup
DJ
News Highlights : Top Company News of the Day - Friday at 5 PM ET
DJ
US FDA panel votes against use of Novo Nordisk's weekly insulin in type 1 diabetes patients
RE
News Highlights : Top Company News of the Day - Friday at 3 PM ET
DJ
Top Midday: Intuit, Workday Shares Tumble on Lowered Guidance; Ozempic Reduces Kidney Disease Events, Deaths From Cardiovascular Causes; NHTSA Finds 9 Additional Incidents Tied to Waymo
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NOVO B Stock
  4. News Novo Nordisk A/S
  5. Highlights
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW